Deborah Cluxton

Deborah Cluxton is a seasoned professional in biochemistry and immunology, currently serving as Senior Manager at Autolus Therapeutics since January 2023, having previously worked in various senior scientific roles at Autolus Ltd. since January 2019. Deborah's expertise includes the identification and validation of new targets for CAR-T therapy and the assessment of drugs to enhance cell therapies. Prior to these roles, Deborah was a Postdoctoral Researcher at AbbVie, focusing on synovial metabolic pathways in rheumatoid arthritis, and conducted similar research at Trinity College Dublin, funded by a Science Foundation Ireland partnership, investigating metabolic influences on immune cell activation. Deborah holds a PhD in Biochemistry and Immunology from Trinity College Dublin and a Postgraduate Certificate in Innovation and Entrepreneurship from a collaborative program involving Queen's University Belfast, Trinity College Dublin, and University College Dublin.